INS and Insulin resistance: The reported analysis supports the hypothesis that if hypogonadal patients who still have active insulin (IS) are treated with TRT, IS will not worsen and lead to insulin resistance (IR) such that the metabolic pathways related to testosterone and insulin cannot be easily recovered.